Oral vaccination against HPV E7 for treatment of cervical intraepithelial neoplasia grade 3 (CIN3) elicits E7-specific mucosal immunity in the cervix of CIN3 patients-Reference-Cited by-同舟云学术

Oral vaccination against HPV E7 for treatment of cervical intraepithelial neoplasia grade 3 (CIN3) elicits E7-specific mucosal immunity in the cervix of CIN3 patients

Published:2014-10 Issue:47 Volume:32 Page:6233-6239
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Kawana Kei,Adachi Katsuyuki,Kojima Satoko,Taguchi Ayumi,Tomio Kensuke,Yamashita Aki,Nishida Haruka,Nagasaka Kazunori,Arimoto Takahide,Yokoyama Terufumi,Wada-Hiraike Osamu,Oda Katsutoshi,Sewaki Tomomitsu,Osuga Yutaka,Fujii Tomoyuki

Funder

Ministry of Health, Labour and Welfare of Japan

Ministry of Education, Culture, Sports, Science and Technology (KK) of Japan

Kanzawa Medical Research Foundation (KK)

Okinawa New Industry Creation Project (TS)

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference40 articles.

1. Papillomavirus and cancer: from basic studies to clinical application;zur Hausen;Nat Rev Cancer,2002

2. Prevalence of HPV infection among females in the United States;Dunne;J Am Med Assoc,2007